ohm: Your comment to Respert that MRK should just buy out
ohm: Your comment to Respert that MRK should just buy out CYDY, get LL approved, and move on from Keytruda is exactly what I have been thinking while diving into the LL/Keytuda CRC clinical trial conjecture and discussion on the board these last few days. Given your assessments that the LL/K combo would be neither synergistic nor capable of extending Keyrtuda's looming 4 year patent cliff, why wouldn't MRK just adopt the Green Bay Packers successful strategy of drafting Aaron Rodgers and then developing him for 3 years while Brett Favre moves through the twilight of his HOF career? MRK doesn't need to extend Keytruda when it can buy at an even better drug with plenty of patent life at a reasonable discount to replace Keytruda by the time the cliff is reached.
Notwithstanding the above, I have seen nothing to support the notion that MRK is pursuing a BO of CYDY. And even the prospect of a MRK/CYDY partnership for oncology indications would be conjectural at best. But it is mind-boggling to me that given Keytruda's patent cliff situation and MRK's many recent clinical trial failures to find a combo drug to extend the patent, that MRK has not become aggressive in pursuing LL in one way or another. Given the LL/Keytruda mouse study, it seems inconceivable that MRK would not be aware of the role of CCR5 in facilitating metastasis in so many lethal conditions and LL's singular ability to block CCR5 from doing such damage.
As you and others have pointed out, NIH funding, if it becomes available, may be the best pathway for CYDY to commercialize LL. But while that pathway has the potential to eventually generate a very high sp, it will also involve far greater risks for ultimate LL approval and the sp than a BO at a reasonable discount against potential value.
If MRK management ever wakes up and acts accordingly, I would welcome the shareholder debate over these alternative pathways.
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Financial Revolution: Bybit Steals the Spotlight Ever been to a tech show where financial bigwigs mingle with code geeks? Well, that's exactly the scene unfolding at the famed Web Summit 2026, with Bybit throwing down the gauntlet as an official partner. The MEO Arena in Lisbon is buzzing more than a stock ticker on a rollercoaster day, as Bybit flaunts its wares to a...
Continue Reading
Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...
Continue Reading
Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...
Continue Reading
Pushing Boundaries: AI and Emergency Room Narratives When you think about the chaos of an emergency room, PTSD might not be the first thing that comes to mind. But for the folks developing cutting-edge AI at NYU Langone Health, it's a crucial window of opportunity. Enter PREVIA, an AI tool that’s been tapping into patients’ narratives to pinpoint PTSD risks with...
Continue Reading
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...
Continue Reading
Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...
Continue Reading
The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...
Continue Reading
Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....
Continue Reading
Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...
Continue Reading
Top 5 Most Recently Viewed Articles
Key Information for MacroGenics, Inc. Investors If you're an investor in MacroGenics, Inc., staying informed about critical legal matters that could impact your investments is essential. This is especially important for those who have incurred losses greater than $100,000. Recent updates regarding a securities class action require your immediate attention. What You Need...
Continue Reading
Revitalizing Real Estate with Innovative Strategies Still Property Group (SPG), a dynamic real estate investment and development firm, is stepping into the spotlight with its bold new initiatives aimed at tackling the critical housing shortage across the nation. Their latest venture involves launching a Regulation D fund specifically designed for innovative property...
Continue Reading
Introduction to the Partnership LG Energy Solution has announced an exciting partnership with Aptera Motors Corp., a leader in the solar electric vehicle sector. This alliance focuses on providing cutting-edge cylindrical batteries designed to power Aptera's innovative solar electric vehicles. The collaboration is poised to drive advancements in sustainable...
Continue Reading
Anticipated Growth in the Potash Market The global potash market is on a promising trajectory, predicted to grow steadily in the forthcoming years. With the rise in the global population, the demand for food is at an all-time high, compelling farmers to boost their agricultural productivity. As a fundamental component for plant sustenance, potash supplies essential...
Continue Reading
Naf Naf Grill Partners with Tractor Beverage Company Naf Naf Grill, known for its delicious Middle Eastern cuisine, is excited to announce a collaboration with Tractor Beverage Company. This partnership brings a new dimension to their dining experience, offering organic, ready-to-drink beverages that perfectly complement their flavorful menu. Elevating the Menu with...
Continue Reading